Jukka Westermarck and his group received the Elias Tillandz -prize

    Jukka Westermarck and his group received the Elias Tillandz -prize

    Prof. Jukka Westermarck and his group received the Elias Tillandz -prize for the best publication of the year for his ground-breaking study on that reveals the druggability of type-2A phosphatase, which has been largely regarded as a non-druggable cancer target. Link to study.

    Warmest congratulations to the whole team!

    Read more:

    Finnish press release

    Swedish press release

     


    Aug 22, 2019 00:00